As of November 2025, according to BIO-TECHNE's current financial statements, the company's 12-month EPS is $0.47. For the year 2025, the company recorded an earnings per share (EPS) of $0.47, which marks a drop compared to its EPS of $1.07 in 2024. BIO-TECHNE's earnings per share for the quarterly report ending on Jun 30, 2025 reached -$0.11.
The annual EPS for the year 2025 was $0.47, a drop of 56.1% from $1.07 in 2024. For the fiscal quarter that ended on Jun 30, 2025, the per-share earnings was -$0.11, showing a 142.3% decrease from the same quarter last year. For the twelve months ending June 2025, the EPS is $0.47. For the year 2024, the yearly earnings per share was $1.07, marking a decrease of 40.9% from 2023.
BIO-TECHNE has registered a decrease in EPS of 142.3% during the last 12 months (YoY, quarterly). In the last three years, TECH recorded an average annual EPS growth rate of -35.2%. BIO-TECHNE had an average annual EPS growth rate of -20.7% during the last 5 years. Across the last decade, TECH had an average annual EPS growth of -4.3%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| STEM Stem Inc | 1.58 | -488.9% | N/A | N/A |
| QGEN Qiagen NV | 25.5 | -74.7% | -44.7% | N/A |
| BDX Becton Dickinson & Co | 30.82 | 18.3% | -5.3% | 8% |
| TMO Thermo Fisher Scientific Inc | 32.78 | 6.8% | -5.5% | 12.4% |
| GE General Electric Co | 40.58 | -28.4% | N/A | N/A |
| DHR Danaher Corp | 43.38 | -17.2% | -15.3% | 5.3% |
| TECH BIO-TECHNE Corp | 125.91 | -56.1% | -35.2% | -20.7% |
| BIO Bio-Rad Laboratories Inc | N/A | -199.5% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.